Protein Coexpression Using FMDV 2A: Effect of “Linker” Residues
Open Access
- 1 January 2013
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2013, 1-12
Abstract
Many biomedical applications absolutely require, or are substantially enhanced by, coexpression of multiple proteins from a single vector. Foot-and-mouth disease virus 2A (F2A) and “2A-like” sequences (e.g.,Thosea asignavirus 2A; T2A) are used widely for this purpose since multiple proteins can be coexpressed by linking open reading frames (ORFs) to form a single cistron. The activity of F2A “cleavage” may, however, be compromised by both the use of shorter versions of F2A and the sequences (derived from multiple-purpose cloning sites) used to link F2A to the upstream protein. To characterise these effects, different lengths of F2A and T2A were inserted between green and cherry fluorescent proteins. Mutations were introduced in the linker region immediately upstream of both F2A- and T2A-based constructs and activities determined using both cell-free translation systems and transfected cells. In shorter versions of F2A, activity may be affected by both the C-terminal sequence of the protein upstream and, equally strikingly, the residues immediately upstream introduced during cloning. Mutations significantly improved activity for shorter versions of F2A but could decrease activity in the case of T2A. These data will aid the design of cloning strategies for the co-expression of multiple proteins in biomedical/biotechnological applications.Keywords
Funding Information
- Medical Research Council (21206133)
This publication has 48 references indexed in Scilit:
- Stable expression and purification of a functional processed Fab′ fragment from a single nascent polypeptide in CHO cells expressing the mCAT-1 retroviral receptorJournal of Immunological Methods, 2011
- Coexpression of double or triple copies of the rabies virus glycoprotein gene using a ‘self-cleaving’ 2A peptide-based replication-defective human adenovirus serotype 5 vectorBiologicals, 2010
- Inhibition of 2A‐mediated ‘cleavage’ of certain artificial polyproteins bearing N‐terminal signal sequencesBiotechnology Journal, 2010
- Virus-free induction of pluripotency and subsequent excision of reprogramming factorsNature, 2009
- Generation of iPS cells using defined factors linked via the self-cleaving 2A sequences in a single open reading frameCell Research, 2009
- Development of optimal bicistronic lentiviral vectors facilitates high-level TCR gene expression and robust tumor cell recognitionGene Therapy, 2008
- Viral 2A peptides allow expression of multiple proteins from a single ORF in transgenic zebrafish embryosGenesis, 2007
- Stable antibody expression at therapeutic levels using the 2A peptideNature Biotechnology, 2005
- Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide–based retroviral vectorNature Biotechnology, 2004
- Retroviral vector-mediated expression of HoxB4 in hematopoietic cells using a novel coexpression strategyGene Therapy, 2001